While the EU’s approval of Leqembi offers new hope for Luxembourg’s Alzheimer’s patients, medical experts warn the expensive treatment only helps early-stage cases and carries potentially life-threatening side effects that exclude many candidates.
A free press doesn’t mean it’s not a tame press. | Evening News. Tomorrow’s News Today. | We Know Where You Live.
While the EU’s approval of Leqembi offers new hope for Luxembourg’s Alzheimer’s patients, medical experts warn the expensive treatment only helps early-stage cases and carries potentially life-threatening side effects that exclude many candidates.